Oxford Immunotec

Commercial-stage diagnostics company using immune markers to diagnose disease

placeAbingdon, England, United Kingdom calendar_todayFounded 2002 groups184 employees language oxfordimmunotec.com

Registered entities

Investor mix

14 investors on record; lead investors include New Leaf Venture Partners, Kaiser Permanente Ventures, Spark Ventures, Draper Esprit.

Investor typeCountShare
Venture capital750%
Private equity214%
Accelerator & incubator214%
Other / undisclosed321%
Coming soon